EUVIMEDEUVIMED entdecken
Open Access

Gabapentin improves neuropathic pain in Minamata disease model rats

Masatake Fujimura

Environmental Health and Preventive Medicine · 2024

DOI: 10.1265/ehpm.24-00035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Health and Preventive Medicine, 2024. Verfasst von Masatake Fujimura. Beteiligte Einrichtung: Department of Basic Medical Sciences, National Institute for Minamata Disease. Hauptthemen laut MEDLINE: Gabapentin, Neuralgia, Disease Models, Animal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Methylmercury (MeHg), the causative agent of Minamata disease, damages the cranial nervous system and causes specific sensory disturbances, especially hypoesthesia, in the extremities. However, recent reports demonstrate that patients with chronic Minamata disease conversely develop neuropathic pain in the lower extremities. Studies on our established Minamata disease model rats showed that MeHg-mediated neurodegeneration might induce neuropathic pain by over time through inducing rewiring with neuronal activation in the somatosensory cortex via microglial activation in the spinal dorsal horn. METHODS: In this study, the effects of gabapentin, a potentially effective treatment for neuropathic pain, was evaluated using this Minamata disease model rats. To further elucidate the mechanism of its medicinal effects, histochemical and biochemical analyses of the nervous system of Minamata disease model rats were conducted. RESULTS: Gabapentin treatment restored the reduction in the pain threshold caused by MeHg exposure in rats. Histochemical and biochemical analyses revealed that gabapentin showed no effect on MeHg-induced neurodegeneration in entire nervous system and microglial activation in the spinal dorsal horn. However, it was shown that gabapentin may reduce excessive synaptogenesis through its antagonist action on the alpha2-delta-1 subunit of calcium channels in the somatosensory cortex. CONCLUSIONS: These results indicate that gabapentin may alleviated neuropathic pain in MeHg poisoning, as typified by Minamata disease, by reversibly modulation synaptic rewiring in the somatosensory cortex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GabapentinNeuralgiaDisease Models, AnimalAnimalsRatsMaleMethylmercury CompoundsAnalgesicsAminesCyclohexanecarboxylic Acidsgamma-Aminobutyric AcidRats, Wistar

Stichwörter der Autor:innen

GabapentinMethylmercuryMinamata diseaseNeuropathic painSomatosensory cortexSynaptic rewiring

Substanzen

GabapentinMethylmercury CompoundsAnalgesicsAminesCyclohexanecarboxylic Acidsgamma-Aminobutyric Acid

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, National Institute for Minamata Disease.

Zitieren

APA

Fujimura, M. (2024). Gabapentin improves neuropathic pain in Minamata disease model rats. Environmental Health and Preventive Medicine. https://doi.org/10.1265/ehpm.24-00035

Vancouver

Fujimura M. Gabapentin improves neuropathic pain in Minamata disease model rats. Environmental Health and Preventive Medicine. 2024. doi:10.1265/ehpm.24-00035

BibTeX
@article{Fujimura2024,
  author = {Fujimura, Masatake},
  title = {Gabapentin improves neuropathic pain in Minamata disease model rats},
  journal = {Environmental Health and Preventive Medicine},
  year = {2024},
  doi = {10.1265/ehpm.24-00035}
}
Kostenlos starten →